US Broker Ratings

Teleflex Incorporated (TFX): Investor Outlook with Attractive 8.26% Potential Upside

Teleflex Incorporated (NYSE: TFX), a major player in the healthcare sector, specializes in the design, development, and manufacture of single-use medical devices. With a market capitalization..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: A 50% Upside Potential in the Healthcare Sector

Investors in Inspire Medical Systems, Inc. (INSP) have reasons to remain optimistic about the company’s future, as analysts project a significant upside potential of 50.16%. With..

Oscar Health, Inc. (OSCR) Stock Analysis: Navigating the Challenges with a 29% Revenue Growth

Oscar Health, Inc. (OSCR), a prominent player in the healthcare technology sector, is navigating a complex financial landscape. As a company that provides innovative health plans..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: Exploring a Potential 51% Upside

Lantheus Holdings, Inc. (NASDAQ: LNTH) stands as a noteworthy contender in the healthcare sector, particularly in the realm of specialty and generic drug manufacturing. Headquartered in..

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: Navigating the Healthcare Giant’s Market Position

Smith & Nephew SNATS, Inc. (NYSE: SNN), a prominent player in the healthcare sector, operates within the medical devices industry. Headquartered in Watford, United Kingdom, the..

West Pharmaceutical Services (WST) Stock Analysis: Uncovering a 27.64% Potential Upside in the Healthcare Sector

West Pharmaceutical Services, Inc. (NYSE: WST) is emerging as a compelling investment opportunity within the robust healthcare sector. With a market capitalization of $17.82 billion, this..

Globus Medical, Inc. (GMED) Stock Analysis: Strong Growth Potential with 32% Upside

Globus Medical, Inc. (NYSE: GMED), a prominent player in the healthcare sector, specializes in developing and commercializing medical devices for musculoskeletal disorders. With a market capitalization..

Telix Pharmaceuticals Limited (TLX) Stock Analysis: Exploring an 82.61% Upside Potential

Investors looking for growth in the healthcare sector may want to turn their attention to Telix Pharmaceuticals Limited (TLX), a promising player in the biotechnology industry..

Alkermes plc (ALKS) Stock Analysis: A 39.5% Potential Upside Captures Investor Attention

Alkermes plc (ALKS), a Dublin-based biopharmaceutical company, is garnering significant interest from the investment community. With a market capitalization of $4.91 billion, the company operates in..

Blueprint Medicines Corporation (BPMC) Stock Analysis: Navigating a 55.5% Revenue Growth in the Biotechnology Sector

Blueprint Medicines Corporation (NASDAQ: BPMC) has garnered attention within the biotechnology sector, particularly for its impressive revenue growth of 55.5%. This Cambridge, Massachusetts-based precision therapy company..

Align Technology, Inc. (ALGN) Stock Report: Exploring a 24.60% Potential Upside

Align Technology, Inc. (NASDAQ: ALGN) stands as a formidable player in the healthcare sector, specifically within the medical instruments and supplies industry. Headquartered in Tempe, Arizona,..

STERIS plc (STE) Stock Analysis: A Healthcare Giant with 8.14% Potential Upside

STERIS plc (NYSE: STE), a prominent player in the healthcare sector, particularly within the medical devices industry, stands as a compelling investment opportunity with a market..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Biotech with a 68.4% Revenue Growth and 18.3% Upside Potential

Sarepta Therapeutics, Inc. (SRPT), a key player in the biotechnology sector, is attracting investor attention with its robust revenue growth and intriguing market potential. Specializing in..

ICON plc (ICLR) Investor Outlook: Navigating a 23% Upside Potential Amidst Market Volatility

ICON plc (NASDAQ: ICLR), a leading clinical research organization headquartered in Dublin, Ireland, has caught the attention of investors with its promising potential upside of 23.30%...

Bausch + Lomb Corporation (BLCO) Stock Analysis: Navigating the Healthcare Sector with Modest Upside and Strategic Vision

Bausch + Lomb Corporation (NYSE: BLCO), a stalwart in the healthcare sector, operates within the medical instruments and supplies industry. With a market cap of approximately..

Qiagen N.V. (QGEN) Stock Analysis: Exploring Growth Potential with a 5.33% Upside

Qiagen N.V. (QGEN) stands out in the diagnostics and research industry, strategically positioned at the intersection of healthcare and technology. Headquartered in Venlo, Netherlands, Qiagen is..

Avidity Biosciences, Inc. (RNA): Exploring a 44.55% Upside in Biotech Innovation

Investors looking for opportunities in the biotechnology sector might find Avidity Biosciences, Inc. (NASDAQ: RNA) an intriguing candidate, especially given its potential upside of 44.55% according..

Halozyme Therapeutics, Inc. (HALO) Stock Report: Analyzing the Biotech Leader’s 179% ROE and Revenue Growth Potential

Halozyme Therapeutics, Inc. (NASDAQ: HALO) stands out in the healthcare sector as a biopharmaceutical company with a robust pipeline and impressive financial metrics that pique investor..

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis: Strong Buy Ratings Amidst 66.80% Revenue Growth

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM), a notable player in the biotechnology sector focusing on rare neuroendocrine diseases, has captured the attention of investors with its impressive..

Henry Schein, Inc. (HSIC) Stock Analysis: Navigating Growth in the Healthcare Sector

Henry Schein, Inc. (NASDAQ: HSIC) is a formidable player in the healthcare sector, focusing on medical distribution. With a market capitalization of $8.44 billion, the company..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds